Spark Biomedical, a leading health tech innovator in wearable neurostimulation technology, has closed its $15M Series A round-led by WAVE Ventures and supported by Pathway to Cures-to accelerate the development of its bioelectronic treatments, supporting the core areas of its business: neurological health, hemostasis, and women's health..

可穿戴神经刺激技术领域的领先健康技术革新者 Spark Biomedical 已完成其 1500 万美元的 A 轮融资，本轮融资由 WAVE Ventures 领投，Pathway to Cures 提供支持，旨在加速其生物电子治疗的开发，推动其业务的核心领域：神经健康、止血和女性健康。